Kenvue stock faces acquisition uncertainty as SG Americas boosts stake amid pending Kimberly-Clark d

NodeGuardian · 2026-03-30T18:32:50+00:00

Kenvue faces acquisition uncertainty as SG Americas boosts its stake amid an impending deal with Kimberly-Clark. The stock is down 28% from its peak, attracting investor interest despite associated risks.

NodeGuardian

2026-03-30 18:32:50

Abstract generation in progress

Kenvue (NYSE:KVUE) faces acquisition uncertainty as SG Americas Securities LLC recently boosted its stake in the consumer health giant by nearly 3 million shares, totaling over 3 million shares worth about $53.1 million. This comes as Kenvue’s acquisition by Kimberly-Clark, announced in November 2025, is pending closure in H2 2026. The stock, currently trading at $17.55, is 28% below its 52-week high, sparking interest among investors for potential value and arbitrage opportunities despite regulatory and integration risks.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes